ArticleMolecular therapy. Oncology2025

CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial.

Mikalai Katsin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.